Osteoporosis Treatment Market
Size is projected to achieve a value of USD 12.21 Billion in 2023, with a
linear behavior in the market growth it is forecasted to achieve a value of USD
19.65 Billion by 2033 with a CAGR of 4.5% during the forecast period 2024-2033.
Osteoporosis treatment primarily focuses on strengthening bones, minimizing bone loss, and preventing fractures. It often involves a combination of lifestyle changes, dietary adjustments, and medications. Weight-bearing exercises and resistance training help improve bone density, while calcium and vitamin D supplements aid in bone health. Medications such as bisphosphonates, hormone therapy, or monoclonal antibodies may be prescribed to prevent further bone weakening. Regular screenings and discussions with healthcare providers assist in personalized treatment plans, aiming to mitigate the risk of fractures and enhance overall bone strength.
We Market Research
global market for therapies for osteoporosis is influenced by various factors.
The aging population worldwide is a major factor propelling market rise,
especially in developed nations where osteoporosis is more prevalent in the
elderly. New methods of early detection and effective management, along with
technical advancements in therapy and diagnostics, are driving market
expansion. Market demand is also influenced by government initiatives that
promote bone health and preventative care, as well as expanding awareness
efforts. In addition, the market is being driven by the increasing need for innovative
medications and treatment choices to address this worldwide health concern as
osteoporosis-related fractures become more prevalent.
Market Size in 2023
Market Forecast in 2033
CAGR % 2024-2033
Consumption, company share, company heatmap, company production capacity,
growth factors and more
By Drug Class, By Route of
Administration ,By Distribution Channel and By Region
Europe, APAC, South America and Middle East and Africa
U.S.; Canada; U.K.; Germany; France;
Italy; Spain; Benelux; Nordic Countries; Russia; China; India; Japan; South
Korea; Australia; Indonesia; Thailand; Mexico; Brazil; Argentina; Saudi
Arabia; UAE; Egypt; South Africa; Nigeria
Osteoporosis Treatment Industry: Dynamics & Restrains
Rising Healthcare Expenditure - The market for osteoporosis
treatments is driven by rising healthcare costs since these costs are being
allocated to more research, cutting-edge treatments, and diagnostic equipment.
The availability of osteoporosis therapeutics is improved as a result of
increased funding for cutting-edge medications, individualized therapy, and
effective healthcare delivery systems brought about by rising healthcare
spending. This increase in funding encourages the development of new drugs and
improves healthcare infrastructures, which in turn leads to improved osteoporosis
treatment options and diagnostic tools. As a result, there is an increase in
demand in the market, which propels development and progress in treating this
bone health issue.
Increasing Aging Population - The market for osteoporosis
treatments is driven by the aging population since age is still a major risk
factor for osteoporosis. Osteoporosis is becoming more common as the number of
older people in the population grows, which increases the need for both
prevention and therapeutic interventions. This shift in the population is
responsible for pharmaceutical research, treatment innovation, and healthcare
programs designed to specifically meet the demands of aging populations. In
addition, a greater emphasis on early detection and intervention due to growing
awareness of the problems with bone health that older people confront is
driving the market for osteoporosis treatments.
Side Effects of Treatment - The market for osteoporosis medicines
may be constrained by the adverse effects of those treatments, which may have
an impact on patient acceptance and adherence. Adverse effects, such as
gastrointestinal problems, musculoskeletal pain, or infrequent but serious
consequences, can occur from several osteoporosis drugs. These adverse effects
frequently cause patients to become reluctant or stop taking their medications,
which has an effect on the market as patients choose non-pharmacological
methods or healthcare practitioners look for other therapy. In order to
mitigate these market constraints, research and development efforts aimed at
minimizing adverse responses and enhancing treatment compliance are encouraged
by the concern over side effects, which highlights the need for safer, more
bearable treatment options.
Osteoporosis Treatment Segmentation
Market- By Drug Class Analysis
By Drug Class, the Osteoporosis Treatment Market is Categories into Hormone Replacement Therapy, Bisphosphonate, RANK ligand Inhibitor, Selective Estrogen Receptor Modulator, Others. The Bisphosphonate segment accounts for the largest share of around 43% in 2022.
A popular class of medications known for
slowing down bone loss and lowering the risk of fractures are called
bisphosphonates. Their demonstrated effectiveness, affordability, and
simplicity of use are the main factors propelling this market. However,
uncommon but dangerous adverse effects such atypical femur fractures and jaw
osteonecrosis may be linked to prolonged use.
following segments are part of an in-depth analysis of the global Osteoporosis
Route of Administration
Retail Pharmacies & Stores
Osteoporosis Treatment Industry: Regional Analysis
North America Market Forecast
America dominate the Osteoporosis Treatment Market with the highest revenue
generating market with share of more than 44%. Osteoporosis is more common in
North America due in large part to the country's aging population. Osteoporosis
is more common as people get older, which raises the need for therapy.
Additionally, a greater market for osteoporosis therapy exists in this region
due to early diagnosis, increasing knowledge of the disease, and access to
state-of-the-art medical facilities.
Europe Market Statistics
is the second-largest market for Osteoporosis Treatment. Osteoporosis diagnosis
and treatment are being improved by a number of government efforts and
healthcare policies, which is driving market expansion. Additionally, developed
healthcare systems in nations like the UK, Germany, and France provide improved
access to diagnosis and treatment, which supports market growth.
APAC Market Forecasts
Pacific is expected to be the fastest-growing market for Osteoporosis Treatment
during the forecast period. Osteoporosis rates are rising in the region due to
urbanization and changing lifestyles, which is driving up demand for therapies.
Other factors driving this trend include dietary changes and decreased physical
activity. Additionally, rising healthcare costs and easier access to
healthcare, especially in developing nations like China and India, support
Osteoporosis Treatment Market is dominated by a few large companies, such as
Novartis International AG
Gilead Sciences, Inc.
Merck & Co., Inc.
F. Hoffmann-La Roche Ltd.
Eli Lilly and Company
Johnson & Johnson
are some of the key trends that are shaping the competitive landscape of the Osteoporosis
August 2021, The Drug
Controller General of India (DCGI) granted Enzene Biosciences Ltd. Marketing
Authorization (MA) for denosumab, a biosimilar medication used to treat
osteoporosis in adults.
August 2019, Terrosa, a
biosimilar teriparatide, was introduced into the European market by GEDEON
Richter after the patent for the reference drug expired. This medicine is
intended to treat two conditions: osteoporosis in postmenopausal women and men
with a high fracture risk, and osteoporosis associated with extended systemic
glucocorticoid therapy in women and men at high fracture risk.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.
Osteoporosis Treatment Market was valued at USD 11.13 Billion in 2022.
Osteoporosis Treatment Market size will increase at approximate CAGR of 4.5% during the forecasted period.
Major companies operating within the Osteoporosis Treatment Market are Novartis International AG, Mylan N.V., Gilead Sciences, Inc., Merck & Co., Inc., F. Hoffmann-La Roche Ltd., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Pfizer Inc., AbbVie Inc., Sanofi, Johnson & Johnson, Sun Pharmaceutical Industries Ltd., GlaxoSmithKline PLC and Other.
North America dominates the market with an active share of 44%.
Only Three Thousand Nine Hundred Fifty US dollar
Only Four Thousand Nine Hundred Fifty US dollar
Only Five Thousand Nine Hundred Fifty US dollar